1. Scrip
  2. >>Archive

Recent Financings of Private Companies (03/2008)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have received venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Feb.—Accumetrics (platelet function assessment tests for patients taking cardiovascular disease therapeutics) raised $28.8mm through its Series D round. Arnerich Massena & Associates and BBT Fund led, and were joined by previous backers Essex Woodlands Health Ventures, RiverVest, PTV Sciences, KB Partners, and Kaiser Permanente Ventures.

Feb.—Start-up diagnostics company Alverix has spun off from Avago Technologies and raised $7.7mm in its Series A financing. Safeguard Scientifics...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from Scrip

Vertex Heralds ‘Unprecedented’ Zimislecel Type 1 Diabetes Data

 
• By Kevin Grogan

The off-the-shelf stem cell therapy shows sustained glycemic control and a high rate of insulin independence.

Pipeline Watch: Ten Approvals And Seventeen Phase III Readouts

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.

Obesity Treatment Could Go Global With Lilly’s Orforglipron

 
• By Andrew McConaghie

The company’s oral GLP-1 candidate has reassured on its safety at the American Diabetes Association meeting, convincing analysts it will open up new global markets.